1. Current topics in the treatment of peptic ulcer

Internal Medicine

Volumn 39, Issue 4, 2000, Pages 339-342

  Asaka, Masahiro ^a   Sugiyama, Toshiro ^a   Kato, Mototsugu ^a   Takeda, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Famotidine; H. pylori; Lansoprazole; NSAIDs; Omeprazole

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; DRUG MIXTURE; GERBIL; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PEPTIC ULCER; RECURRENT DISEASE; STOMACH ACID SECRETION; STOMACH PH;

ANTI-ULCER AGENTS; HUMANS; PEPTIC ULCER;

EID: 0034109251     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.339     Document Type: Conference Paper

References (12)

1. Saigenji K, Harasawa S, Iwasaki A, et al. Risk factors for duodenal ulcer recurrence: three-year follow-up during famotidine maintenance therapy. Dig Endosc 7: 226-233, 1995.
2. Takeda H, Hokari K and Asaka M. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring. J Clin Gastroenterol 20 Suppl 1: S7-S9, 1995.
3. 2-receptor blockade in normal subjects and duodenal ulcer patients. Gut 31: 148-150, 1990.
4. Miyoshi A, Yachi A, Goto Y, et al. Evaluation of the clinical usefulness of omeprazole for gastric ulcer; Comparison with famolidine in a multicenter double-blind study. Yakuri to Chiryou 16 Suppl 3: 543-561, 1988.
5. Miyoshi A, Yachi A, Goto Y, et al. Evaluation of the clinical usefulness of omeprazole for duodenal ulcer; Comparison with famotidine in a multicenter double-blind study. Yakuri to Chiryou 16 Suppl 3: 563-582, 1988.
6. Takemoto T, Namiki M, Goto Y, et al. Evaluation of the clinical usefulness of lansoprazole (AG-1749) for gastric ulcer; Comparison with famotidine in a multicenter double-blind study. Rinsho Seijinbyou 21: 327-347, 1991.
7. Takemoto T, Namiki M, Goto Y, et al. Evaluation of the clinical usefulness of lansoprazole (AG-1749) for duodenal ulcer; Comparison with famotidine in a multicenter double-blind study. Rinsho Seijinbyou 21: 613-631, 1991.
8. Gough KR, Korman MG, Bardhan KD, et al. Ranitidine and cimetidine in prevention of duodenal ulcer relapse. Lancet II: 659-662, 1984.
9. Lauritsen K, Rune SJ, Bytzer P, et al. Effect of omeprazole and cimetidine on duodenal ulcer. A double blind comparative trial. N Engl J Med 312: 958-961, 1985.
10. Hirayama F, Takagi S, Kusuhara H, et al. Induction of gastric ulcer and intestinal metaplasia in Mongolian gerbils infected with Helicobacter pylori J Gastroenterol 31: 755-757, 1996.
11. Lind T, Veldhuyzen van Zanten S, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH 1 study. Helicobacter 1: 138-144, 1996.
12. Clinical Trial Review Committee of the Japanese Society of Gastroenterology. Guidelines for clinical trials on eradication of Helicobacter pylori. Japanese Journal of Gastroenterology 96: 199, 1998.